A single 70 mg vial reconstituted with 2 mL of bacteriostatic water yields the following per-component working concentrations: GHK-Cu: 25 mg/mL (50 mg / 2 mL) = 25,000 mcg/mL BPC-157: 5 mg/mL (10 mg / 2 mL) = 5,000 mcg/mL TB-500: 5 mg/mL (10 mg / 2 mL) = 5,000 mcg/mL Other diluent volumes scale linearly
Separate products provide independent dose control -- essential when testing different ratios, conducting dose-response experiments, or when one peptide is the primary interest
The published research literature has investigated: Gene expression modulation across hundreds of genes (documented in microarray studies) Collagen synthesis and skin remodeling Tissue protection through antioxidant and copper-dependent mechanisms Wound healing and dermatological research Various aging-related cellular processes The mechanisms don't overlap meaningfully
The effects of iron deficiency in tissues and reduced activity of iron-containing enzymes, such as growth retardation, abnormal behavior, and physical deficiency, can therefore be gradually corrected after active iron supplementation in iron-deficient animals, in addition to accelerating hemoglobin synthesis
Consequently, the lion's share of BPC-157 research has focused on its potential in these areas
